Literature DB >> 18335322

Serum pro-inflammatory cytokines in physiological and pre-eclamptic pregnancies.

Martina Montagnana1, Giuseppe Lippi, Alessandro Albiero, Gian Luca Salvagno, Massimo Franchi, Gian Cesare Guidi.   

Abstract

BACKGROUND: Pre-eclampsia is a heterogeneous syndrome ranging from mild hypertension and proteinuria to severe pre-eclampsia with complications, which can also be associated with an enhanced maternal inflammatory response.
METHODS: Tumor necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1), interleukin-6 (IL-6) and interferon-gamma (IFN-gamma) were evaluated by multiplexed sandwich enzyme-linked immunosorbent assay in 14 pre-eclamptic women, 57 normotensive pregnant women (20 in the first, 20 in the second and 17 in the third trimester) and 21 non-pregnant women.
RESULTS: The concentration of serum TNF-alpha was lower than the sensitivity limit of the assay in all groups. The prevalence of measurable IL-1 and IL-6 values, but not that of IFN-gamma, increased significantly in the second and third trimesters of pregnancy. However, the percentage of subjects with higher or detectable values of pro-inflammatory cytokines was statistically different between pre-eclamptic women and those in the second and third trimester of physiological pregnancy.
CONCLUSIONS: Results of this study do not support standard screening for pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6 and IFN-gamma) in pre-eclampsia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18335322     DOI: 10.1080/09513590801895575

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  8 in total

1.  Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies.

Authors:  Kelly K Ferguson; John D Meeker; Thomas F McElrath; Bhramar Mukherjee; David E Cantonwine
Journal:  Am J Obstet Gynecol       Date:  2016-12-30       Impact factor: 8.661

2.  Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection?

Authors:  Roberto Romero; Nicholas Kadar; Edi Vaisbuch; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2010-03-15       Impact factor: 3.886

3.  Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls.

Authors:  Brandie D Taylor; Gong Tang; Roberta B Ness; Jørn Olsen; David M Hougaard; Kristin Skogstrand; James M Roberts; Catherine L Haggerty
Journal:  Pregnancy Hypertens       Date:  2015-11-10       Impact factor: 2.899

4.  Cytokine concentrations direct endothelial function in pregnancy and preeclampsia.

Authors:  Amanda K Mauro; Nauman Khurshid; Danielle M Berdahl; Amanda C Ampey; Daniel Adu; Dinesh M Shah; Derek S Boeldt
Journal:  J Endocrinol       Date:  2021-02       Impact factor: 4.286

5.  Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women.

Authors:  N Vitoratos; E Economou; C Iavazzo; K Panoulis; G Creatsas
Journal:  Mediators Inflamm       Date:  2010-12-28       Impact factor: 4.711

6.  The immunomodulatory role of syncytiotrophoblast microvesicles.

Authors:  Jennifer Southcombe; Dionne Tannetta; Christopher Redman; Ian Sargent
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

7.  Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study.

Authors:  Mei Du; Arpita Basu; Dongxu Fu; Mingyuan Wu; Michael Centola; Alicia J Jenkins; Kristian F Hanssen; Satish K Garg; Samar M Hammad; James A Scardo; Christopher E Aston; Timothy J Lyons
Journal:  Diabetes Care       Date:  2013-02-07       Impact factor: 19.112

8.  Body weight gain and serum leptin levels of non-overweight and overweight/obese pregnant women.

Authors:  Didier Silveira Castellano Filho; José Otávio do Amaral Correa; Plínio Dos Santos Ramos; Marina de Oliveira Montessi; Beatriz Julião Vieira Aarestrup; Fernando Monteiro Aarestrup
Journal:  Med Sci Monit       Date:  2013-11-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.